John Chan
John Chan is a technology executive, trained as a scientist and engineer, with over 25 years of industry experience in computational sciences and informatics. He has led computational teams, built informatics capabilities, and translated ideas into products for global biopharma and biotech start-ups. He is currently the head of the Shinrai Center for AI and Machine Learning at Takeda R&D. Prior to joining Takeda, John built a neuroscience AI company, Syllable Life Sciences, and as its CEO, led its acquisition by Neumora. Before Syllable, John held several contributor and management roles in computational biology, bioinformatics, and enterprise IT. This includes tenure as a visiting scientist at the Broad Institute, an Executive Director and Head of Informatics and Technology at Novartis, and the Head of computational biology at Millennium Pharmaceuticals, where he led the innovative team that fueled Millennium’s drug discovery partnerships. John earned a B.Sc. in population genetics from Marlboro College and a Ph.D. in genetics and molecular biology from the University of Pennsylvania.